Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : C3 ( CTHR ) Diamond in the rough? -- Ignore unavailable to you. Want to Upgrade?

To: Gigi Snyder who wrote (115)	7/2/1998 4:17:00 PM
From: Leslie S. Feinberg	Respond to of 226

Gigi; Thanks for your post. I'm anxious to hear what you think of the larger stones when you receive your order. The stones I have seen were about 4mm and were lovely. I spoke to another jeweler after my last post, again a Floridian. Sole proprietor, gemnologist. He told me that he thinks the resistance to moissanite from some diamond jewelers is a product of fear and misunderstanding. He tells me that the C3 product will only impact the low end of the diamond business, someone who want an investment grade diamond always will and a manmade product will never be an investment piece as there is no limit to the quantity that can be produced. He thinks the big loser here will be ALL other simulants, they are so much less durable and so inferior visually that he thinks that industry will be wiped out by moissanite. He also mentioned that he has read that production a few weeks ago was running at 15,000 carats/ mo., that before the shipment of equipment that Hunter said would double capacity. At 30,000 carats/mo. sales... well, you do the math. And that's just the beginning, gives me spine tingles. I just bought more at $8.5 Les